Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Vesale Bioscience Sprl |
| Country | Belgium |
| Start Date | Feb 01, 2023 |
| End Date | Oct 31, 2025 |
| Duration | 1,003 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190150004 |
Personalised phage therapy using magistral preparations of phages is among the most promising solutions to fight antimicrobial resistant infections, but this approach requires a rapid diagnostic that identifies the pathogen(s) involved in the infection and the phages active on them.
Vsale Bioscience has developed the Phagogram, the first automated in-vitro diagnostic tool that enables a fast determination of bacteriophages suitable for treating a particular bacterial infection.
It consists of a basic test kit (a disposable well plate with reagents), a high-performance luminometer and a dedicated software that proposes the best matching phage cocktail to treat the patient.
Compared to the current diagnostic methodologies, which take up to 4-7 days, the Phagogram compares the activity of up to 96 phages on a bacterial culture within 2-3 hours, making phage susceptibility testing accessible for hospital microbiology labs and enabling personalized therapy on a routine basis.
Vesale Bioscience Sprl
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant